Recombinant Rat RAC1 Protein Pre-coupled Magnetic Beads

• Cat.No.: RAC1-4567R-B
• Product Overview: The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations.

Specification

• Source: HEK293
• Species: Rat
• Form: Solution
• Particle size: ~2 μm
• Beads Surface: Hydrophilic
• Capacity: > 200 pmol rabbit IgG/ mg beads
• Applications: Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification.
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions.
• Storage: 2-8℃. Do not to freeze thaw the Beads
• Concentration: 10mg beads/mL
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Rac1 ras-related C3 botulinum toxin substrate 1 [ Rattus norvegicus ]
• Official Symbol: RAC1
• Gene ID: 363875
• mRNA Refseq: NM_134366.1
• Protein Refseq: NP_599193.1
• UniProt ID: Q6RUV5

Reviews

05/03/2022

RAC1 protein is highly recommended for researchers and scientists due to its exceptional performance in ELISA assays.

12/20/2021

Its reliability in ELISA makes it a trusted tool for quantitative and qualitative protein analysis.

12/22/2018

With its superior binding affinity and specificity, RAC1 protein enables accurate and reliable detection of target analytes in various biological samples.

Q&As

Are there any ongoing clinical trials targeting RAC1 for therapeutic purposes?

Yes, there are clinical trials investigating the efficacy of RAC1-targeted therapies in various diseases, including cancer and inflammatory disorders.

How does RAC1 influence the progression of diabetic complications?

RAC1 activation is implicated in the development of diabetic complications, particularly in the context of vascular dysfunction and diabetic nephropathy.

Can RAC1 be a biomarker for neurodegenerative diseases?

Research suggests that altered RAC1 expression and activity may serve as a biomarker for certain neurodegenerative diseases.

In what ways does RAC1 impact neuronal function, and how does this relate to neurological disorders?

RAC1 is crucial for neurite outgrowth and synaptic plasticity, and its dysregulation has been implicated in neurological disorders, suggesting a potential target for therapeutic interventions.

How does RAC1 contribute to cardiovascular diseases, and what are the potential therapeutic interventions?

RAC1 is involved in vascular smooth muscle cell migration, and its dysregulation is associated with cardiovascular diseases. Targeting RAC1 may offer therapeutic benefits in such cases.